These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38167290)
21. Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells. Liu H; Xu C; Diplas BH; Brown A; Strickland LM; Yao H; Ling J; McLendon RE; Keir ST; Ashley DM; He Y; Waitkus MS Neuro Oncol; 2023 Sep; 25(9):1563-1575. PubMed ID: 36689342 [TBL] [Abstract][Full Text] [Related]
22. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. Li F; Wang Y; Hwang I; Jang JY; Xu L; Deng Z; Yu EY; Cai Y; Wu C; Han Z; Huang YH; Huang X; Zhang L; Yao J; Lue NF; Lieberman PM; Ying H; Paik J; Zheng H Nat Commun; 2023 Mar; 14(1):1756. PubMed ID: 36991019 [TBL] [Abstract][Full Text] [Related]
23. Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA. Rose AM; Goncalves T; Cunniffe S; Geiller HEB; Kent T; Shepherd S; Ratnaweera M; O'Sullivan RJ; Gibbons RJ; Clynes D Nucleic Acids Res; 2023 Jul; 51(13):6509-6527. PubMed ID: 36940725 [TBL] [Abstract][Full Text] [Related]
24. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT). De Vitis M; Berardinelli F; Sgura A Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031 [TBL] [Abstract][Full Text] [Related]
25. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes. Min J; Wright WE; Shay JW Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773 [TBL] [Abstract][Full Text] [Related]
27. Alternative Lengthening of Telomeres in the Budding Yeast Cohn M; Andersson AK; Mateo RQ; Möller MC G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453 [TBL] [Abstract][Full Text] [Related]
29. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs. Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537 [TBL] [Abstract][Full Text] [Related]
30. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood. Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680 [TBL] [Abstract][Full Text] [Related]
31. Telomeres: Implications for Cancer Development. Bernal A; Tusell L Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351238 [TBL] [Abstract][Full Text] [Related]
32. Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia. Samassekou O; Malina A; Hébert J; Yan J J Hematol Oncol; 2013 Apr; 6():26. PubMed ID: 23547895 [TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT). Falcinelli M; Dell'Omo G; Grassi E; Mariella E; Leto SM; Scardellato S; Lorenzato A; Arena S; Bertotti A; Trusolino L; Bardelli A; d'Adda di Fagagna F Cell Death Dis; 2023 Feb; 14(2):96. PubMed ID: 36759506 [TBL] [Abstract][Full Text] [Related]
34. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer. Mori JO; Keegan J; Flynn RL; Heaphy CM J Clin Pathol; 2024 Jan; 77(2):82-86. PubMed ID: 37890990 [TBL] [Abstract][Full Text] [Related]
35. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK; PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774 [TBL] [Abstract][Full Text] [Related]
36. [Telomere Recombination in Normal Mammalian Cells]. Zhdanova NS; Rubtsov NB Genetika; 2016 Jan; 52(1):14-23. PubMed ID: 27183789 [TBL] [Abstract][Full Text] [Related]
37. The role of telomere biology in cancer. Xu L; Li S; Stohr BA Annu Rev Pathol; 2013 Jan; 8():49-78. PubMed ID: 22934675 [TBL] [Abstract][Full Text] [Related]
38. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. Henson JD; Reddel RR FEBS Lett; 2010 Sep; 584(17):3800-11. PubMed ID: 20542034 [TBL] [Abstract][Full Text] [Related]
39. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Grobelny JV; Kulp-McEliece M; Broccoli D Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632 [TBL] [Abstract][Full Text] [Related]
40. A unified alternative telomere-lengthening pathway in yeast survivor cells. Kockler ZW; Comeron JM; Malkova A Mol Cell; 2021 Apr; 81(8):1816-1829.e5. PubMed ID: 33639094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]